Immediate Impact
20 standout
Citing Papers
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Novel strategies to manage CAR-T cell toxicity
2025 Standout
Works of Amber B. Koehler being referenced
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice
2020
A Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel BTK Inhibitor, Dtrmwxhs-12 (DTRM-12), in Combination with Everolimus and Pomalidomide in Patients with Relapsed/Refractory CLL, DLBCL or Other B-Cell Lymphomas
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Amber B. Koehler | 278 | 213 | 21 | 81 | 28 | 324 | |
| Aileen Cohen | 257 | 234 | 9 | 73 | 30 | 348 | |
| Gerasimos Pangalis | 223 | 177 | 11 | 73 | 21 | 363 | |
| Shenmiao Yang | 166 | 142 | 5 | 81 | 35 | 279 | |
| Amie Fonder | 191 | 107 | 15 | 43 | 30 | 281 | |
| Eva Gimeno | 117 | 143 | 3 | 73 | 35 | 348 | |
| Pablo Mozas | 121 | 208 | 6 | 81 | 35 | 266 | |
| Kevin Tay | 69 | 182 | 11 | 101 | 22 | 313 | |
| Alessia Castellino | 98 | 266 | 5 | 26 | 34 | 336 | |
| C. Nerl | 132 | 172 | 4 | 161 | 24 | 362 | |
| Jaimal Kothari | 114 | 125 | 3 | 34 | 35 | 296 |
All Works
Login with ORCID to disown or claim papers
Loading papers...